Friday, November 18, 2022

Drugs "evergreening" clause in India-UK FTA attracts criticism

Intro:

India-UK Free Trade Agreement is attracting controversy after the medical journal Lancet said one of its clauses could hurt the National Health Service in the UK.

A leaked draft showed that the agreement allows companies to refile patents for medicines – after making small changes to it – a process known as evergreening.

Ishan Garg has more from New Delhi.

IN: Concerns are that...
OUT: SOC
Duration: 42 seconds